Nucleotide vector vaccine for immunization against hepatitis
US7825097B2 · kind B2 · utility
2Cited by
29References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 20, 2003 |
| Grant date | Nov 2, 2010 |
| Priority date | — |
| Expiry date | Aug 29, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Nucleotide vector comprising at least one gene or one complementary DNA coding for at least a portion of a virus, and a promoter providing for the expression of such gene in muscle cells. The gene may be the S gene of the hepatitis B virus.A vaccine preparation containing said bare DNA is injected into the host previously treated with a substance capable of inducing a coagulating necrosis of the muscle fibres.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.